CD8A and neoplasm: Hypoxia-mediated ALKBH5 is reported to significantly accelerate TAM recruitment and immunosuppression [134] and the m6A methyltransferase METTL14 in TAMs induces CD8+ T cell dysfunction and tumor progression [149].